Success Story: Neuroscience Researcher from Italy Secures I-140 NIW Approval for Chronic Pain Research
Client’s Testimonial:
“Thank you again for your support throughout my I-140 journey.”
On August 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Research Fellow
Country of Origin: Italy
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 18th, 2026
Processing Time: 12 months, 21 days (Premium Processing Upgrade Requested)
Case Summary:
Improving chronic pain care increasingly depends on research that can identify meaningful biomarkers, support safer treatment strategies, and better explain the relationship between pain and cognitive health. The client’s research operates at the intersection of neuroscience, neuroimaging, neuromodulation, biomedical signal analysis, and machine learning, with a focus on discovering biomarkers in chronic pain patients and assessing future responses to specific interventions.
The client holds a Ph.D. in biomarkers of chronic and complex diseases and is currently employed as a research fellow at a U.S.-based hospital and research institution. In this role, the client continues to conduct research involving chronic pain, brain network analysis, placebo and nocebo effects, non-invasive neuromodulation, clinical assessments, data collection, data analysis, and manuscript preparation. Her current work closely aligns with the proposed endeavor described in the I-140 NIW petition.
For National Interest Waiver petitions, the strongest cases demonstrate not only that a proposed endeavor serves an important national objective, but also that the researcher has already built a record showing the ability to advance that objective. North America Immigration Law Group structured the petition around these considerations, highlighting the broader significance and potential impact of the client’s research in neuroscience and related areas.
The petition was supported by 2 expert recommendation letters. One expert offered the following assessment:
“Given the breakthroughs that her research has fostered in these areas and the field of neuroscience more generally, ensuring that [Client’s] work proceeds is thus not only important to the field but to the United States as well.”
NAILG organized the evidence so USCIS could evaluate the client’s impact through clear, objective indicators:
- Peer-review activity: at least 21 completed reviews for authoritative journals in neuroscience and related fields.
- Publication record: 20 peer-reviewed journal articles, including 8 first-authored articles, 11 conference abstracts, including 6 first-authored abstracts, and 1 first-authored book chapter.
- Citation reliance: 727 citations by researchers in the field.
Rather than presenting these metrics as automatically sufficient, the petition explained how they demonstrated the client’s influence within the field. Independent researchers had cited and relied on the client’s work in studies involving machine learning-based neurological assessment, biomedical signal analysis, neurodegenerative disease detection, and other related applications.
USCIS approved the I-140 National Interest Waiver petition without a Request for Evidence, recognizing a record defined by meaningful scholarly influence, independent reliance by other researchers, trusted peer-review service, expert support, and sustained contributions to nationally important neuroscience research. Filed on July 28th, 2025, later upgraded to premium processing, and approved on August 18th, 2026, this case supports the client’s continued work in advancing chronic pain research, cognitive health, and safer treatment strategies in the United States.